Litcius/Paper detail

COVID-19 in a Patient Treated for Granulomatosis with Polyangiitis: Persistent Viral Shedding with No Cytokine Storm

Pascale Daniel, Marc Raad, Rami Waked, Jacques Choucair, Moussa Riachy, Fadi Haddad

2020European Journal of Case Reports in Internal Medicine17 citationsDOIOpen Access PDF

Abstract

INTRODUCTION: The coronavirus disease COVID-19 is considered a pandemic disease that has developed rapidly all over the world. As of today, it is unclear whether immunosuppression confers an increased risk for pulmonary complications, or conversely, whether it can be a protective factor with respect to a cytokine storm. CASE DESCRIPTION: We report the case of a 55-year-old male patient with granulomatosis with polyangiitis treated with rituximab who was infected with COVID-19 pneumonia. To the best of our knowledge, only 1 case has been reported in the literature with similar characteristics. The patient had a non-classic evolution of clinical symptoms with persistent fever and viral shedding, in addition to a negative serology. CONCLUSION: This case emphasizes the management and immunity response to COVID-19 pneumonia in such patients. Data are still needed regarding patients who have prolonged B-cell depletion, which may put the patient at a higher risk for reinfection. LEARNING POINTS: Demonstration of the immunity response to COVID-19 pneumonia in an immunosuppressed patient.To highlight the management and evolution of such rare cases during this pandemic.

Topics & Concepts

Cytokine stormMedicineImmunosuppressionCoronavirus disease 2019 (COVID-19)Viral sheddingPandemicGranulomatosis with polyangiitisPneumoniaRituximabImmunologyViral pneumoniaDiseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Infectious disease (medical specialty)Internal medicineVasculitisVirusAntibodyVasculitis and related conditionsCOVID-19 Clinical Research StudiesHematological disorders and diagnostics